Status:
TERMINATED
A Study of Losartan Compared to Losartan/HCTZ in Pediatric Patients With Hypertension (0954A-327)
Lead Sponsor:
Organon and Co
Conditions:
Hypertension
Eligibility:
All Genders
6-17 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to test the safety and effectiveness of Losartan as compared to Losartan/HCTZ in pediatric patients (6 to 17 years) with high blood pressure.
Detailed Description
Participants who meet eligibility requirements will enter the single-blind Filter Period. Participants with either sitting systolic blood pressure (SiSBP) or sitting diastolic blood pressure (SiDBP) \...
Eligibility Criteria
Inclusion
- Patient is male/female and 6 to 17 years of age at the time of study with hypertension (high blood pressure)
- Patient is able to swallow tablets
- Females of child bearing potential must use acceptable contraception throughout the trial
Exclusion
- Patient has a history of heart, metabolic or kidney disease
- Patient has a history of known heart, lung, liver and other body system disorders
- Patient is pregnant or nursing
- Patient has participated in another clinical trial within the last 28 days
Key Trial Info
Start Date :
May 24 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 22 2007
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00447603
Start Date
May 24 2007
End Date
October 22 2007
Last Update
June 18 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.